Table 1.
CKD | |||||
---|---|---|---|---|---|
Sham | Control | AST‐120 | Carnitine | Teneligliptin | |
BUN (mg/dL) | 21.1 ± 1.2 | 56.7 ± 9.4b | 45.5 ± 6.0a | 53.9 ± 9.4b | 66.9 ± 12.8b |
SCr (mg/dL) | 0.2 ± 0.02 | 0.8 ± 0.31a | 0.4 ± 0.13 | 1.4 ± 0.42a | 1.0 ± 0.05b |
Final BW (g) (at 28 weeks) | 49.1 ± 2.7 | 39.3 ± 1.4a | 44.2 ± 0.5 | 45.4 ± 1.4 | 43.4 ± 0.9 |
Tibialis anterior (mg) | 74.6 ± 3.3 | 70.0 ± 2.6 | 71.5 ± 1.7 | 74.0 ± 2.7 | 75.0 ± 3.7 |
Soleus (mg) | 12.5 ± 0.6 | 10.3 ± 0.3a | 10.7 ± 0.6 | 11.5 ± 0.5 | 11.3 ± 0.4 |
Gastrocnemius (mg) | 216.0 ± 6.6 | 188.9 ± 9.1a | 212.0 ± 5.5 | 211.0 ± 6.2 | 207.6 ± 6.2 |
Data are expressed as the mean ± standard error of the mean.
p < 0.05.
p < 0.01 compared with sham.
CKD, chronic kidney disease; BUN, blood urea nitrogen; SCr, serum creatinine; BW, body weight.